SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Laser Vision Centers, Inc. (NASDAQ: LVCI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: W Shakespeare who wrote (407)2/16/2001 11:26:19 AM
From: Robert G. Harrell  Read Replies (1) of 413
 
Hi Will,
I found this little nugget this morning from Bank of America Securities:
<<snip>>
VISX, INCORPORATED (EYE) MARKET PERFORMER Price: $16.03 Target Price:
Strong 1Q01 U.S. Procedure Volumes Prompts Increase In Estimates

? Based on anecdotal information from a number of different industry sources, 1Q01 U.S. refractive
procedure volumes appear to be pacing at a much stronger rate than we had previously estimated.


? We are raising our Visx 1Q01 EPS estimate to $0.19 from $0.17 and our 2001 estimate to $0.79
from $0.74 to reflect a higher level of procedure volumes, we are raising our forecast for 1Q01 Visx
sequential procedure volume growth to 10% from 5%.
<<snip>>
investor.cnet.com
I'm still holding about 4k shares bought at 5 1/4 down from over 10k bought at much higher prices. This and Visx have been great lessons in listening to the market rather than to the analysts. I lost a bunch on them.
Good luck,
Bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext